Does OSIMERTINIB Cause Acquired gene mutation? 474 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 474 reports of Acquired gene mutation have been filed in association with OSIMERTINIB (TAGRISSO). This represents 1.7% of all adverse event reports for OSIMERTINIB.
474
Reports of Acquired gene mutation with OSIMERTINIB
1.7%
of all OSIMERTINIB reports
71
Deaths
27
Hospitalizations
How Dangerous Is Acquired gene mutation From OSIMERTINIB?
Of the 474 reports, 71 (15.0%) resulted in death, 27 (5.7%) required hospitalization, and 4 (0.8%) were considered life-threatening.
Is Acquired gene mutation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 474 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Acquired gene mutation?
GEFITINIB (250)
LAMIVUDINE (157)
CYCLOPHOSPHAMIDE (151)
DOXORUBICIN (138)
VINCRISTINE (124)
RITUXIMAB (122)
PREDNISOLONE (120)
TENOFOVIR DISOPROXIL (80)
CARBOPLATIN (64)
NEVIRAPINE (62)
Which OSIMERTINIB Alternatives Have Lower Acquired gene mutation Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN